Decidualization was assessed by measuring secreted IGFBP1 protein levels within the conditioned media after 1–7 days of treatment with 8-Br-cAMP and MPA between the 4 control samples and 8 PCOS samples. The gene discussed is IGFBP1; the disease is polycystic ovary syndrome.